| Synonyms: | |
| Status: | Approved (2022) |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | OYN3CCI6QE |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Gastric inhibitory polypeptide receptor agonist |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family B G protein-coupled receptor
Peptide receptor (family B GPCR)
Glucagon-like receptor
Gastric inhibitory polypeptide receptor
|
0.03 | - | - | - | - | |
|
Membrane receptor
Family B G protein-coupled receptor
Peptide receptor (family B GPCR)
Glucagon-like receptor
Glucagon-like peptide receptor
|
0.77 | - | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials |
| Non-alcoholic Fatty Liver Disease | 2 | D065626 | ClinicalTrials |
| Wolfram Syndrome | 2 | D014929 | ClinicalTrials |
| Obesity, Morbid | 2 | D009767 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 2023788-19-2 |
| ChEMBL | CHEMBL4297839 |
| FDA SRS | OYN3CCI6QE |
CONTENTS